SignalGene acquires Nova Molecular

SignalGene (TSE:SGI), a genomics drug discovery company, will acquire Nova (Montreal, Quebec), a pharmacogenomics company, through the issue of 3.4 million SGI shares worth C$6.9 million ($4.6 million...